This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Nov;20(11):2014-7.

doi: 10.1038/mt.2012.220.

rAAV-mediated tumorigenesis: still unresolved after an AAV assault

Paul N Valdmanis¹, Leszek Lisowski, Mark A Kay

Affiliations

PMID: 23131853
PMCID: PMC3498811
DOI: 10.1038/mt.2012.220

Comment

rAAV-mediated tumorigenesis: still unresolved after an AAV assault

Paul N Valdmanis et al. Mol Ther. 2012 Nov.

. 2012 Nov;20(11):2014-7.

doi: 10.1038/mt.2012.220.

Authors

Paul N Valdmanis¹, Leszek Lisowski, Mark A Kay

Affiliation

¹ Departments of Pediatrics and Genetics, Stanford University, Stanford, California 94305, USA.

PMID: 23131853
PMCID: PMC3498811
DOI: 10.1038/mt.2012.220

No abstract available

PubMed Disclaimer

Figures

Figure 1
Overview of the rate of oncogenesis and the identified integrated genes. rAAV, recombinant adeno-associated virus; SCID, severe combined immunodeficient.

See this image and copyright information in PMC

Comment on

Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity.
Rosas LE, Grieves JL, Zaraspe K, La Perle KM, Fu H, McCarty DM. Rosas LE, et al. Mol Ther. 2012 Nov;20(11):2098-110. doi: 10.1038/mt.2012.197. Epub 2012 Sep 18. Mol Ther. 2012. PMID: 22990674 Free PMC article.

Similar articles

Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity.
Rosas LE, Grieves JL, Zaraspe K, La Perle KM, Fu H, McCarty DM. Rosas LE, et al. Mol Ther. 2012 Nov;20(11):2098-110. doi: 10.1038/mt.2012.197. Epub 2012 Sep 18. Mol Ther. 2012. PMID: 22990674 Free PMC article.
AAV vector integration sites in mouse hepatocellular carcinoma.
Donsante A, Miller DG, Li Y, Vogler C, Brunt EM, Russell DW, Sands MS. Donsante A, et al. Science. 2007 Jul 27;317(5837):477. doi: 10.1126/science.1142658. Science. 2007. PMID: 17656716
Evaluating the state of the science for adeno-associated virus integration: An integrated perspective.
Sabatino DE, Bushman FD, Chandler RJ, Crystal RG, Davidson BL, Dolmetsch R, Eggan KC, Gao G, Gil-Farina I, Kay MA, McCarty DM, Montini E, Ndu A, Yuan J; American Society of Gene and Cell Therapy (ASGCT) Working Group on AAV Integration. Sabatino DE, et al. Mol Ther. 2022 Aug 3;30(8):2646-2663. doi: 10.1016/j.ymthe.2022.06.004. Epub 2022 Jun 10. Mol Ther. 2022. PMID: 35690906 Free PMC article. Review.
[Integration of AAV vectors and insertional mutagenesis].
Rossi A, Salvetti A. Rossi A, et al. Med Sci (Paris). 2016 Feb;32(2):167-74. doi: 10.1051/medsci/20163202010. Epub 2016 Mar 2. Med Sci (Paris). 2016. PMID: 26936174 Review. French.
Recombinant adeno-associated virus integration sites in murine liver after ornithine transcarbamylase gene correction.
Zhong L, Malani N, Li M, Brady T, Xie J, Bell P, Li S, Jones H, Wilson JM, Flotte TR, Bushman FD, Gao G. Zhong L, et al. Hum Gene Ther. 2013 May;24(5):520-5. doi: 10.1089/hum.2012.112. Hum Gene Ther. 2013. PMID: 23621841 Free PMC article.

See all similar articles

Cited by

Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy.
Chandler RJ, LaFave MC, Varshney GK, Trivedi NS, Carrillo-Carrasco N, Senac JS, Wu W, Hoffmann V, Elkahloun AG, Burgess SM, Venditti CP. Chandler RJ, et al. J Clin Invest. 2015 Feb;125(2):870-80. doi: 10.1172/JCI79213. Epub 2015 Jan 20. J Clin Invest. 2015. PMID: 25607839 Free PMC article.
Human Immune Responses to Adeno-Associated Virus (AAV) Vectors.
Ronzitti G, Gross DA, Mingozzi F. Ronzitti G, et al. Front Immunol. 2020 Apr 17;11:670. doi: 10.3389/fimmu.2020.00670. eCollection 2020. Front Immunol. 2020. PMID: 32362898 Free PMC article. Review.
Gene therapy for the heart: encapsulated viruses to the rescue.
Deshetty UM, Sil S, Buch S. Deshetty UM, et al. Extracell Vesicles Circ Nucl Acids. 2024 Feb 26;5(1):114-118. doi: 10.20517/evcna.2023.70. eCollection 2024. Extracell Vesicles Circ Nucl Acids. 2024. PMID: 39698416 Free PMC article.
Hitting the target without pulling the trigger.
VandenDriessche T, Chuah MK. VandenDriessche T, et al. Mol Ther. 2015 Jan;23(1):4-6. doi: 10.1038/mt.2014.230. Mol Ther. 2015. PMID: 25561034 Free PMC article. No abstract available.
Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery.
Nidetz NF, McGee MC, Tse LV, Li C, Cong L, Li Y, Huang W. Nidetz NF, et al. Pharmacol Ther. 2020 Mar;207:107453. doi: 10.1016/j.pharmthera.2019.107453. Epub 2019 Dec 11. Pharmacol Ther. 2020. PMID: 31836454 Free PMC article. Review.

See all "Cited by" articles

References

1. Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasco JJ.et al. (2006Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response Nat Med 12342–347. - PubMed
1. Nathwani AC, Tuddenham EG, Rangarajan S, Rosales C, McIntosh J, Linch DC.et al. (2011Adenovirus-associated virus vector-mediated gene transfer in hemophilia B N Engl J Med 3652357–2365. - PMC - PubMed
1. Gaudet D, Méthot J, Déry S, Brisson D, Essiembre C, Tremblay G.et al. (2012Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPL(S447X)) gene therapy for lipoprotein lipase deficiency: an open-label trial Gene Ther published online 21 June 2012; doi:10.1038/gt.2012.43). - PubMed
1. Bennett J, Ashtari M, Wellman J, Marshall KA, Cyckowski LL, Chung DC.et al. (2012AAV2 gene therapy readministration in three adults with congenital blindness Sci Transl Med 4120ra115 - PMC - PubMed
1. Miller DG, Wang PR, Petek LM, Hirata RK, Sands MS., and, Russell DW. Gene targeting in vivo by adeno-associated virus vectors. Nat Biotechnol. 2006;24:1022–1026. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

R01 HL064274/HL/NHLBI NIH HHS/United States

LinkOut - more resources

Full Text Sources